【國藥集團新冠疫苗生產能力到2021年將超過10億支】

據國藥集團董事長劉景珍介紹，到2021年，國藥集團新冠肺炎疫苗的生產能力將超過10億劑。從開發滅活疫苗到獲得有條件的上市許可，只花了335天。截至目前，國藥集團已在全球範圍內使用了4300多萬劑國藥滅活疫苗。China National Pharmaceutical Group's（Sinopharm）production capacity for inactivated COVID-19 vaccines will exceed one billion doses in 2021，according to Sinopharm's Chairman Liu Jingzhen. Sinopharm has gained attention for its achievements in the battle against COVID-19. It developed nucleic acid test kits within 48 hours，and successfully prepared plasma for COVID-19 patients in severe situations. It took only 335 days from developing an inactivated vaccine to obtaining the conditional marketing authorization. Up to now，more than 43 million doses of inactivated Sinopharm vaccines have been used worldwide.